Iontotherapeutic device and process and iontotherapeutic unit dose

• US 5,961,482 A
• Filed: 03/19/1996
• Issued: 10/05/1999
• Est. Priority Date: 07/25/1986
• Status: Expired due to Fees

• Current Assignee: Rutgers University
• Original Assignee: Rutgers University
• Inventors: Sun, Ying, Chien, Yie W., Siddiqui, Ovais, Li, John Kong-Jiann, Shi, Wei-Min, Liu, Jue-Chen
• Primary Examiner(s): Bockelman, Mark
• Application Number:
  US08/617,688
• Time in Patent Office: 1,295 Days
• Field of Search: 604/20, 607/152, 607/115
• US Class Current: 604/20
• CPC Class Codes: A61K 9/0009 involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis microelectromechanical systems A61K9/0097
• CPC Class Codes: A61N 1/0432 Anode and cathode
• CPC Class Codes: A61N 1/044 Shape of the electrode
• CPC Class Codes: A61N 1/303 Constructional details electrodes for external use A61N1/0428
• CPC Class Codes: A61N 1/325 for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body electrodes for external use A61N1/0428

Abstract

This invention relates to development of an iontotherapeutic device for regulated transdermal systemic administration of ionizable pharmaceutical compounds. It also provides an iontotherapeutic process for transdermal administration of ionized pharmaceuticals, particularly those which are otherwise transdermally absorbed to a small degree or not all, such as peptide pharmaceuticals, for example, insulins. The invention also relates to unit dose forms, for example, those in which an ionized pharmaceutical is dispersed in a hydrophilic polymer. The unit dose is adapted to be assembled as part of the pharmaceutical reservoir electrode, so that the ionized pharmaceutical will be delivered transdermally and then be absorbed systemically when the iontotherapeutic device is in operation.

Claims

1. A lightweight, portable transdermal periodic iontotherapeutic device for transdermal administration of a systemically-effective amount of an ionized peptide pharmaceutical, which is adapted to be worn by a subject being iontotherapeutically treated, comprising:

1) a DC power supply capable of providing an iontotherapeutically effective and physiologically acceptable DC current in the range up to about 10 mA;

2) a periodic waveform generator electrically connected to the DC power supply and having integrated circuitry capable of providing a) a periodic waveform in the square, triangular, sinusoidal, trapezoidal, or combination thereof;

b) an on/off ratio of 1/50 to 10/1; and

c) a repetition frequency from about 10 Hz to about 50 kHz;

3) an output circuit electrically connected to said waveform generator which a) can provide a periodic DC current in a pre-selected waveform of said forms;

b) monitors current intensity delivered;

c) adjusts and maintains the current intensity within predetermined maximum and minimum levels and d) delivers the current to a reservoir electrode for iontotherapeutic transdermal administration of said peptide pharmaceutical;

4) a pharmaceutical reservoir electrode which can be preselected to be either the cathode or the anode depending upon whether the ionized pharmaceutical is anionic or cationic;

said electrode having a receptacle adapted to receive a unit dose of said peptide pharmaceutical in which a peptide is in aqueous solution at a pH at least 1.0 pH unit below or above the isoelectric point of said peptide;

said electrode with said received unit dose adapted to be placed in electrical contact with the intact skin to be treated iontotherapeutically;

said electrode having a terminal to receive and to transmit through said unit dose the said DC periodic current and said unit dose adapted to be in electrical contact with said terminal;

5) receptor electrode adapted to be in electrical contact with the intact skin to be treated and forming with said pharmaceutical reservoir electrode a combination of anode and cathode electrodes;

said electrodes electrically connected to said output circuit and providing when placed upon the skin of a subject being treated a current path through the intervening tissue of the subject being treated; and

6) a programmable control element electrically integrated within said device to preprogram and to control said iontotherapeutic administration on an automated basis.

2. A device of claim 1 wherein the device is a wrist-band type.

3. A transdermal periodic iontotherapeutic process for administering a controlled and systemically effective amount of an ionized pharmaceutical which is stable for transdermal administration and is transdermally absorbable using a device as defined in claim 1, byentering instructions for administering said pharmaceutical into the control element of said device;

2) assembling a dosage unit containing a pharmaceutically acceptable aqueous solution of said ionized pharmaceutical into a receptacle of a reservoir electrode of said device, which electrode is a cathode or anode depending upon whether said ionized peptide is anionic or cationic, said solution having a pH at least about 1.0 pH unit below or above the isoelectric or pKa point of said pharmaceutical;

3) placing the cathode and anode electrodes of said transdermal periodic iontotherapeutic device in electrical contact with the intact skin to be treated;

4) applying upon command of said control element an iontotherapeutically effective, periodic DC current of up to about 10 mA based on a reservoir electrode/skin-contacting area of about 5 cm² using a) a periodic waveform in the square, triangular, sinusoidal, trapezoidal, or combination thereof, b) a physiological acceptable repetition frequency of at least 10 Hz, and c) an on/of ratio of from 1/50 to 10/1;

said process providing a systemically effective absorption of said ionized pharmaceutical from said solution at a rate of at least 500 percent from that provided by passive diffusion transdermal absorption from said solution during an administration time of at least 2 hours.

4. The process of claim 3 wherein the solution is an insulin solution having a pH which is at least about 1.5 pH units lower or higher than the isoelectric point of the insulin, the current intensity not more than about 2 mA based on a reservoir electrode/skin-contacting area of about 5 cm², the administration times are not more than about 40 minutes, and the repetition frequency is at least about 1000 Hz.

5. The process of claim 3 in which the pH of the pharmaceutical solution is at least about 1.5 pH units below or above the isoelectric or pKa point of said pharmaceutical.

6. The process of claim 3 in which the pH of the pharmaceutical solution is at least about 2.0 pH units below or above the isoelectric or pKa point of said pharmaceutical.

7. The process of claim 3 in which the pH of the pharmaceutical solution is at least about 1.5 or 1.0 pH units below the isoelectric or pKa point of said pharmaceutical.

8. The process of claim 3 in which the ionized pharmaceutical is insulin and the pH of the insulin solution is in the range of about pH 3.0 to pH 4.0.

9. The process of claim 8 in which the pH of the insulin solution is about pH 3.6.

10. The process of claim 3 in which the current intensity is not more than about 5 mA based on a reservoir electrode/skin-contacting area of about 5 cm².

11. The process of claim 3 in which the current intensity is not more than about 2 mA based on a reservoir electrode/skin-contacting area of about 5 cm².

12. The process of claim 3 in which the current intensity is not more than 1 mA based on a reservoir electrode/skin-contacting area of about 5 cm².

13. An iontotherapeutic device for transdermal administration of a systemically-effective amount of an ionized pharmaceutical in a unit dose through intact skin of a subject being treated, the device comprising:

a signal generator that is operable to provide a periodic waveform with an on/off ratio of 1/50 to 10/1 and a repetition frequency from about 10 Hz to about 50 kHz so as to provide an iontotherapeutically effective and physiologically acceptable DC periodic current in the range up to about 10 mA;

a reservoir electrode having a receptacle adapted to receive the unit dose of the peptide pharmaceutical in which the peptide is in aqueous solution at a pH at least 1.0 pH unit below or above the isoelectric point of the peptide;

the reservoir electrode further adapted to be placed in electrical contact with the intact skin;

the reservoir electrode further having a terminal to receive and to transmit through the unit dose the DC periodic current and the unit dose adapted to be in electrical contact with the terminal;

an output circuit coupled to the signal generator, the output circuit being operable to deliver the current to the reservoir electrode and to monitor current intensity delivered;

a receptor electrode adapted to be in electrical contact with the intact skin to be treated, the receptor and reservoir electrodes coupled to the output circuit so as to provide a current path through the intervening tissue of the subject; and

a programmable control element electrically integrated within the device to program and to control the iontotherapeutic administration on an automated basis.

14. The device of claim 13, wherein the signal generator produces a squarewave output signal.

15. The device of claim 13, wherein the device comprises a wrist-band type device.